Allianz’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Sell
89,438
-9,206
-9% -$2.15M 0.24% 47
2026
Q1
$24.1M Sell
98,644
-36,522
-27% -$8.51M 0.27% 41
2025
Q4
$28M Buy
135,166
+3,554
+3% +$703K 0.36% 34
2025
Q3
$24.4M Sell
131,612
-1,609
-1% -$276K 0.52% 31
2025
Q2
$20.3M Sell
133,221
-8,085
-6% -$1.24M 0.48% 38
2025
Q1
$23.4M Buy
141,306
+8,629
+7% +$1.35M 0.63% 30
2024
Q4
$19M Sell
132,677
-4,527
-3% -$702K 0.49% 38
2024
Q3
$22.2M Buy
137,204
+12,760
+10% +$2.03M 0.6% 31
2024
Q2
$18.2M Sell
124,444
-3,557
-3% -$529K 0.53% 35
2024
Q1
$20.2M Buy
+128,001
New +$20.4M 0.64% 29

Other funds holding JNJ

Allianz's JNJ Position: Q2 2026 in Review

Allianz reduced its Johnson & Johnson (JNJ) stake by 9.3% in Q2 2026, selling an estimated $2.15M and leaving 89,438 shares worth $22.7M. The position accounts for 0.24% of the portfolio, ranked #47.

Allianz first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. The position peaked at $28M in Q4 2025. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Allianz held 89,438 shares of Johnson & Johnson worth $22.7M as of Q2 2026.
  • Allianz sold 9,206 Johnson & Johnson shares in Q2 2026, an estimated $2.15M.
  • Johnson & Johnson made up 0.24% of Allianz's portfolio in Q2 2026, its #47 holding.
  • Allianz first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Johnson & Johnson position peaked at $28M in Q4 2025.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.